Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.65
-0.2300-0.52%
Post-market: 43.55-0.0978-0.22%18:44 EDT
Volume:17.97M
Turnover:784.79M
Market Cap:63.26B
PE:17.69
High:43.97
Open:43.74
Low:43.30
Close:43.88
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.03
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.54
PE(LYR):22.50

Loading ...

US FDA - Classifies Imager Ii Angiographic Catheter Recall as Class I Due to Injury Risk

THOMSON REUTERS
·
Sep 26

US FDA - Boston Scientific Reports Two Serious Injuries, no Deaths from Imager Ii Catheter Defect

THOMSON REUTERS
·
Sep 26

Boston Scientific Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

US Companies Face Rise in Cyber Attacks

Reuters
·
Sep 23

Boston Scientific MedSurg, Asia Pacific Chief Arthur Butcher to Retire Jan. 1, 2027

Reuters
·
Sep 23

Movement Alert|Boston Scientific Rises 3.02% in Regular Trading, New Product Approval in China and Maintained Analyst Optimism Boost Sentiment

Market Focus
·
Sep 23

Option traders moderately bearish in Boston Scientific with shares down 0.38%

TIPRANKS
·
Sep 22

Boston Scientific Price Target Cut to $65.00/Share from $85.00 by Oppenheimer

Dow Jones
·
Sep 21

Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating

MT Newswires Live
·
Sep 21

Boston Scientific Corp. : Oppenheimer Cuts Target Price to $65 from $85

THOMSON REUTERS
·
Sep 21

Boston Scientific Shares Fall After Citigroup Downgrade

MT Newswires Live
·
Sep 18

Boston Scientific Price Target Cut to $50.00/Share from $57.00 by Citigroup

Dow Jones
·
Sep 17

U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical

Reuters
·
Sep 17

Citi Downgrades Boston Scientific, Citing Uncertain Road Ahead

Reuters
·
Sep 17

Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57

MT Newswires Live
·
Sep 17

Boston Scientific Corp : Citigroup Cuts to Neutral from Buy; Cuts Target Price to $50 from $57

THOMSON REUTERS
·
Sep 17

Boston Scientific downgraded to Neutral from Buy at Citi

TIPRANKS
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

Movement Alert|Boston Scientific Falls 3.04% in Regular Trading, Multiple Investment Banks Cut Target Prices Amid Lingering Cybersecurity Concerns

Market Focus
·
Sep 15

Boston Scientific Corp : Bernstein Cuts Target Price to $60 from $72

THOMSON REUTERS
·
Sep 15